Luoxin Pharmaceuticals Group Stock Co., Ltd. (002793.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap5.1B
Enterprise Value5.81B
P/E Ratio-18.28
PEG Ratio-0.15
Price/Sales Ratio2.11
Price/Book Ratio4.55
Enterprise/Revenue2.37
Enterprise/EBITDA-51.53

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.11
Operating Margin-0.1
AD

Management Effectiveness

Return On Assets-0.08
Return On Equity-0.21

Income Statement

Revenue2.27B
Revenue/Share2.18
Gross Profit1.13B
EBITDA-29.17M
Net Income-288.58M
Diluted EPS-0.27

Balance Sheet

Total Cash806.45M
Total Cash/Share0.74
Total Debt1.41B
Total Debt/Equity1.29
Current Ratio0.76
Book Value Per Share1.08

Price History

52-Week Change-8
52-Week High6.74
52-Week Low3.7
Moving Average 50 Days4.52
Moving Average 200 Days4.93

Statistics

Average Volume31.26M
Shares Outstanding1.09B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.12
Last Split Factor17:10
Last Split DateSeptember 23, 2019
AD